Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Praxis Precision Medicines, Inc. (PRAX) had Free Cash Flow per Share of $-7.36 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$8.55M |
|
$-182.82M |
|
-- |
|
$8.55M |
|
$208.72M |
|
$-200.16M |
|
$17.35M |
|
$-182.82M |
|
$-182.82M |
|
$-182.82M |
|
$-182.82M |
|
$-182.82M |
|
$-182.82M |
|
$-200.16M |
|
$-204.82M |
|
17.91M |
|
17.91M |
|
$-10.21 |
|
$-10.21 |
|
| Balance Sheet Financials | |
$404.37M |
|
$0.23M |
|
$78.74M |
|
$483.11M |
|
$37.55M |
|
-- |
|
$0.11M |
|
$37.66M |
|
$445.45M |
|
$445.45M |
|
$445.45M |
|
19.42M |
|
| Cash Flow Statement Financials | |
$-131.76M |
|
$-248.49M |
|
$514.32M |
|
$81.72M |
|
$215.79M |
|
$134.07M |
|
$41.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2340.29% |
|
-2340.29% |
|
-2394.68% |
|
-2137.48% |
|
-2137.48% |
|
$-131.76M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-41.04% |
|
-41.04% |
|
-37.84% |
|
-41.04% |
|
$22.94 |
|
|
Free Cash Flow per Share |
$-7.36 |
$-7.36 |
|